Error message

  • An illegal choice has been detected. Please contact the site administrator.

Centre for Inflammation and Disease Research

The innate immune system has a central role in inflammation-driven diseases.

When it identifies danger, for example an injury or a pathogen, innate immunity triggers a chain of events to restore homeostasis. This response is called inflammation. Inflammation is essential for eliminating agents that may cause harm and for healing, but if uncontrolled, it can cause enormous damage. In fact, inflammation is a key driver of most diseases. It is a system of incredible influence. Researchers at the Centre for Inflammation and Disease Research (CIDR) are developing a detailed understanding of how this process works, so they can devise strategies to control it. If they can block or reduce inflammation when it is unchecked, they may be able to develop new approaches to tackle many important and common diseases. 

The ultimate goal of CIDR is to develop new biomarkers and therapies, so that we can identify, prevent and/or treat the underlying causes of many inflammation-related diseases. These include inflammatory bowel diseases, fatty liver disease, sepsis, arthritis, asthma, cancer, obesity-related conditions such as type 2 diabetes, cardiovascular diseases, and neurodegenerative diseases like Alzheimer’s and Parkinson’s disease.


General information and enquiries

Research enquiries
Professor Matt Sweet
Director, IMB Centre for Inflammation and Disease Research
Phone: +61 7 3346 2082

Partner with IMB


Make a difference to our research by making a donation